A review of the management of central retinal artery occlusion

Reema Madike; Sudha Cugati; Celia Chen

doi:10.4103/2211-5056.353126

A review of the management of central retinal artery occlusion

Taiwan J Ophthalmol. 2022 Aug 18;12(3):273-281. doi: 10.4103/2211-5056.353126. eCollection 2022 Jul-Sep.

Authors

Reema Madike¹, Sudha Cugati², Celia Chen³

Affiliations

¹ The University of Adelaide School of Medicine, Adelaide, Australia.
² Department of Ophthalmology, Modbury Hospital, South Australia Institute of Ophthalmology, South Australia, Australia.
³ Department of Ophthalmology, Flinders Medical Centre and Flinders University, South Australia, Australia.

Abstract

Central retinal artery occlusion (CRAO), the ocular analog of a cerebral stroke, is an ophthalmic emergency. The visual prognosis for overall spontaneous visual recovery in CRAO is low. Furthermore, the risk of future ischemic heart disease and cerebral stroke is increased due to the underlying atherosclerotic risk factors. There is currently no guideline-endorsed treatment for CRAO. This review will describe the anatomy, pathophysiology, epidemiology, and clinical features of CRAO, and investigate the current and future management strategies.

Keywords: Central retinal artery; Ischemia; occlusion; prevention; reperfusion; thrombolysis.

Publication types

Review